Jacob Thyssen, PhD, discusses tralokinumab's promising results for hand eczema, highlighting its potential to transform treatment options for patients.
Jacob Pontoppidan Thyssen, PhD
Advertisement
Jacob Pontoppidan Thyssen, PhD, is chief scientific officer and executive vice president of science, search, and innovation at LEO Pharma.
Articles by Jacob Pontoppidan Thyssen, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Reviewing Type 2 Inflammation Through a Different Lens
3
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
4
How Clinicians are Navigating JAK Inhibitors and Patient Expectations in Alopecia Areata
5
